MAM
ABBV icon

Majedie Asset Management’s AbbVie ABBV Stock Holding History

Majedie Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-12,219
Closed -$706K – 66
2014
Q3 		$706K Buy
12,219
+3,852
+46% +$214K 0.12% 34
2014
Q2 		$472K Buy
+8,367
New +$439K 0.11% 20

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Majedie Asset Management's ABBV Position: Q4 2014 in Review

Majedie Asset Management sold out of AbbVie (ABBV) in Q4 2014, closing a stake of 12,219 shares — an estimated $706K sold.

Majedie Asset Management first reported a position in ABBV in Q2 2014 and held it in 2 quarters. The position peaked at $706K in Q3 2014. 1,606 funds tracked by Wall St. Rank hold ABBV as of Q4 2014.

  • Majedie Asset Management reported no remaining AbbVie position as of Q4 2014 after selling out during the quarter.
  • Majedie Asset Management sold 12,219 AbbVie shares in Q4 2014, an estimated $706K.
  • Majedie Asset Management first reported a position in AbbVie in Q2 2014 and held it in 2 quarters.
  • Majedie Asset Management's AbbVie position peaked at $706K in Q3 2014.
  • 1,606 funds tracked by Wall St. Rank held AbbVie as of Q4 2014.

Based on Majedie Asset Management's 13F filing for Q4 2014, filed 4 Feb 2015.